In cellular and mouse models of Huntington’s disease, DnaJB2 and DnaJB6 reduce mutant Huntingtin aggregation and delay the onset of Huntington’s disease, whereas other JDPs do not significantly suppress aggregation (86, 87, 88, 89, 90). This evidence concerns the gene HTT and Huntington disease.